858
Views
72
CrossRef citations to date
0
Altmetric
Review

Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis – a review

&
Pages 237-255 | Published online: 14 Aug 2015

References

  • ZoetendalEGVaughanEEde VosWMA microbial world within usMol Microbiol20065961639165016553872
  • PituchAWalkowiakJBanaszkiewiczAButyric acid in functional constipationPrz Gastroenterol20138529529824868272
  • KuwaharaAContributions of colonic short-chain fatty acid receptors in energy homeostasisFront Endocrinol20145144
  • RoyallDWoleverTMJeejeebhoyKNClinical significance of colonic fermentationAm J Gastroenterol19908510130713122220719
  • LeonelAJAlvarez-LeiteJIButyrate: implications for intestinal functionCurr Opin Clin Nutr Metab Care201215547447922797568
  • PuertollanoEKolidaSYaqoobPBiological significance of short-chain fatty acid metabolism by the intestinal microbiomeCurr Opin Clin Nutr Metab Care201417213914424389673
  • BuckmanSAHeiseCPNutrition considerations surrounding restorative proctocolectomyNutr Clin Pract201025325025620581318
  • ClausSPElleroSLBergerBColonization-induced host-gut microbial metabolic interactionMBio201122e00271e0031021363910
  • GuarnerFMalageladaJRGut flora in health and diseaseLancet2003361935651251912583961
  • BelkaidYHandTWRole of the microbiota in immunity and inflammationCell2014157112114124679531
  • MolloyMJBouladouxNBelkaidYIntestinal microbiota: shaping local and systemic immune responsesSemin Immunol2012241586622178452
  • ForsythePBienenstockJImmunomodulation by commensal and probiotic bacteriaImmunol Invest2010394–542944820450286
  • CaniPDMetabolism in 2013: the gut microbiota manages host metabolismNat Rev Endocrinol2014102747624322652
  • AbreuMTToll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal functionNat Rev Immunol201010213114420098461
  • KimYSHoSBIntestinal goblet cells and mucins in health and disease: recent insights and progressCurr Gastroenterol Rep201012531933020703838
  • JohanssonMEPhillipsonMPeterssonJVelcichAHolmLHanssonGCThe inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteriaProc Natl Acad Sci U S A200810539150641506918806221
  • OuwerkerkJPde VosWMBelzerCGlycobiome: bacteria and mucus at the epithelial interfaceBest Pract Res Clin Gastroenterol2013271253823768550
  • SwidsinskiALoening-BauckeVKirschSDoerffelYBiostructure fonctionnelle du microbiote colique (zone de fermentation centrale, zone de réserve germinale et couche de mucus séparatrice) chez les sujets sains et chez les patients atteints de diarrhée traités par Saccharomyces boulardii [Functional biostructure of colonic microbiota (central fermenting area, germinal stock area and separating mucus layer) in healthy subjects and patients with diarrhea treated with Saccharomyces boulardii]Gastroenterol Clin Biol201034Suppl 1S79S92 French20889010
  • SwidsinskiALoening-BauckeVHerberAMucosal flora in Crohn’s disease and ulcerative colitis – an overviewJ Physiol Pharmacol200960Suppl 6617120224153
  • StrugalaVDettmarPWPearsonJPThickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn’s diseaseInt J Clin Pract200862576276918194279
  • MussoGGambinoRCassaderMObesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?Diabetes Care201033102277228420876708
  • FernandesJSuWRahat-RozenbloomSWoleverTMComelliEMAdiposity, gut microbiota and faecal short chain fatty acids are linked in adult humansNutr Diabetes20144e12124979150
  • StokholmJSchjorringSEskildsenCEAntibiotic use during pregnancy alters the commensal vaginal microbiotaClin Microbiol Infect201420762963524118384
  • O’SullivanOCoakleyMLakshminarayananBAlterations in intestinal microbiota of elderly Irish subjects post-antibiotic therapyJ Antimicrob Chemother201368121422122949626
  • GroverMRole of gut pathogens in development of irritable bowel syndromeIndian J Med Res20141391111824604037
  • SchneiderSMLe GallPGirard-PipauFTotal artificial nutrition is associated with major changes in the fecal floraEur J Nutr200039624825511395984
  • SchneiderSMNutrition entérale et microbiote [Microbiota and enteral nutrition]Gastroenterol Clin Biol201034Suppl 1S57S61 French20889006
  • O’KeefeSJOuJDelanyJPEffect of fiber supplementation on the microbiota in critically ill patientsWorld J Gastrointest Pathophysiol20112613814522180847
  • NakaoMOguraYSatakeSUsefulness of soluble dietary fiber for the treatment of diarrhea during enteral nutrition in elderly patientsNutrition2002181353911827762
  • CheyWDCashBDIrritable bowel syndrome: update on colonic neuromuscular dysfunction and treatmentCurr Gastroenterol Rep20068427328116888868
  • GhoshalUCSrivastavaDIrritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hypeWorld J Gastroenterol201420102482249124627585
  • WalkerAWSandersonJDChurcherCHigh-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel diseaseBMC Microbiol201111721219646
  • ThomasLVOckhuizenTSuzukiKExploring the influence of the gut microbiota and probiotics on health: a symposium reportBr J Nutr2014112Suppl 1S1S1824953670
  • SurawiczCMLe microbiote dans les diarrhées infectieuses [The microbiota and infectious diarrhea]Gastroenterol Clin Biol201034Suppl 1S29S36 French20889002
  • KollingGWuMGuerrantRLEnteric pathogens through life stagesFront Cell Infect Microbiol2012211422937528
  • MaCWuXNawazMMolecular characterization of fecal microbiota in patients with viral diarrheaCurr Microbiol201163325926621739252
  • ThabaneMKottachchiDTMarshallJKSystematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndromeAliment Pharmacol Ther200726453554417661757
  • BarbaraGStanghelliniVBerti-CeroniCRole of antibiotic therapy on long-term germ excretion in faeces and digestive symptoms after Salmonella infectionAliment Pharmacol Ther20001491127113110971228
  • VothDEBallardJDClostridium difficile toxins: mechanism of action and role in diseaseClin Microbiol Rev200518224726315831824
  • WangLConlonMAChristophersenCTSorichMJAngleyMTGastrointestinal microbiota and metabolite biomarkers in children with autism spectrum disordersBiomark Med20148333134424712423
  • KangDWParkJGIlhanZEReduced incidence of Prevotella and other fermenters in intestinal microflora of autistic childrenPLoS One201387e6832223844187
  • SwidsinskiALoening-BauckeVKrügerMKirschSCentral nervous system and the colonic bioreactor: analysis of colonic microbiota in patients with stroke unravels unknown mechanisms of the host defense after brain injuryIntest Res2012104332342
  • KimuraIOzawaKInoueDThe gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43Nat Commun20134182923652017
  • MoayyediPThe epidemiology of obesity and gastrointestinal and other diseases: an overviewDig Dis Sci20085392293229918636328
  • KanauchiOMatsumotoYMatsumuraMFukuokaMBambaTThe beneficial effects of microflora, especially obligate anaerobes, and their products on the colonic environment in inflammatory bowel diseaseCurr Pharm Des20051181047105315777254
  • ForsterCTight junctions and the modulation of barrier function in diseaseHistochem Cell Biol20081301557018415116
  • ThanabalasuriarAKoutsourisAWeflenAMimeeMHechtGGruenheidSThe bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coliCell Microbiol2010121314119712078
  • ShenLTight junctions on the move: molecular mechanisms for epithelial barrier regulationAnn N Y Acad Sci2012125891822731710
  • SwidsinskiALoening-BauckeVVerstraelenHOsowskaSDoerffelYBiostructure of fecal microbiota in healthy subjects and patients with chronic idiopathic diarrheaGastroenterology2008135256857918570896
  • SwidsinskiAUngVSydoraBCBacterial overgrowth and inflammation of small intestine after carboxymethylcellulose ingestion in genetically susceptible miceInflamm Bowel Dis200915335936418844217
  • ZhuLLiuWAlkhouriRStructural changes in the gut microbiome of constipated patientsPhysiol Genomics2014461867968625073603
  • ChassardCDapoignyMScottKPFunctional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndromeAliment Pharmacol Ther201235782883822315951
  • CzeruckaDPicheTRampalPReview article: yeast as probiotics – Saccharomyces boulardiiAliment Pharmacol Ther200726676777817767461
  • LitiGCarterDMMosesAMPopulation genomics of domestic and wild yeastsNature2009458723633734119212322
  • MacKenzieDADefernezMDunnWBRelatedness of medically important strains of Saccharomyces cerevisiae as revealed by phylogenetics and metabolomicsYeast200825750151218615862
  • BlehautHMassotJElmerGWLevyRHDisposition kinetics of Saccharomyces boulardii in man and ratBiopharm Drug Dispos19891043533642758101
  • ElmerGWMcFarlandLVSurawiczCMDankoLGreenbergRNBehaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patientsAliment Pharmacol Ther199913121663166810594402
  • BarcMCCharrin-SarnelCRochetVMolecular analysis of the digestive microbiota in a gnotobiotic mouse model during antibiotic treatment: influence of Saccharomyces boulardiiAnaerobe200814422923318511310
  • MunozPBouzaECuenca-EstrellaMSaccharomyces cerevisiae fungemia: an emerging infectious diseaseClin Infect Dis200540111625163415889360
  • LlopisSQuerolAHeykenATranscriptomics in human blood incubation reveals the importance of oxidative stress response in Saccharomyces cerevisiae clinical strainsBMC Genomics20121341922916735
  • Perez-TorradoRLlopisSPerroneBGomez-PastorRHubeBQuerolAcomparative genomic analysis reveals a critical role of de novo nucleotide biosynthesis for Saccharomyces cerevisiae virulencePLoS One2015103e012238225816288
  • Edwards-IngramLGitshamPBurtonNGenotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiaeAppl Environ Microbiol20077382458246717293506
  • GraffSChaumeilJCBoyPLai-KuenRCharrueauCInfluence of pH conditions on the viability of Saccharomyces boulardii yeastJ Gen Appl Microbiol200854422122718802321
  • CzeruckaDNanoJLBernasconiPRampalPEffect of Saccharomyces boulardii on cholera toxin-induced camp level in rat epithelial intestinal cell linesGastroenterol Clin Biol1989133833872544474
  • ElmerGWCorthierGModulation of Clostridium difficile induced mortality as a function of the dose and the viability of the Saccharomyces boulardii used as a preventative agent in gnotobiotic miceCan J Microbiol19913743153171913342
  • SchwenzerVSaccharomyces boulardiiDeutsche Apotheker Zeitung19981387577
  • DinleyiciECKaraAOzenMVandenplasYSaccharomyces boulardii CNCM I-745 in different clinical conditionsExpert Opin Biol Ther2014117
  • McFarlandLVSystematic review and meta-analysis of Saccharomyces boulardii in adult patientsWorld J Gastroenterol201016182202222220458757
  • ZanelloGMeurensFBerriMSalmonHSaccharomyces boulardii effects on gastrointestinal diseasesCurr Issues Mol Biol2009111475818780946
  • McFarlandLVUse of probiotics to correct dysbiosis of normal micro-biota following disease or disruptive events: a systematic reviewBMJ Open201448e005047
  • MicklefieldGSaccharomyces coulardii bei Antibiotika-assoziierter Diarrhöe [Saccharomyces boulardii with antibiotic-associated diarrhea]MMW-Fortschritte der Medizin Originalien20141561 Suppl1822 German
  • NaXKellyCProbiotics in Clostridium difficile infectionJ Clin Gastroenterol201145SupplS154S15821992956
  • TungJMDolovichLRLeeCHPrevention of Clostridium difficile infection with Saccharomyces boulardii: a systematic reviewCan J Gastroenterol2009231281782120011734
  • KollaritschHHolstHGrobaraPWiedermannGProphylaxe der reisediarrhoe mit Saccharomyces boulardii [Prevention of traveler’s diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study]Fortschr Med19931119152156 German8486328
  • FeizizadehSSalehi-AbargoueiAAkbariVEfficacy and safety of Saccharomyces boulardii for acute diarrheaPediatrics20141341e176e19124958586
  • GuandaliniSProbiotics for children with diarrhea: an updateJ Clin Gastroenterol200842Suppl 2S53S5718520336
  • WhelanKEnteral-tube-feeding diarrhoea: manipulating the colonic microbiota with probiotics and prebioticsProc Nutr Soc200766329930617637081
  • TempeJDSteidelALBlehautHHasselmannMLutunPMaurierFPrévention per Saccharomyces boulardii des diarrhées de l’alimentation entérale à débit continu [Prevention of diarrhea administering Saccharomyces boulardii during continuous enteral feeding]Sem Hop1983591814091412 French6306827
  • SchlottererMBernasconiPLebretonFIntérêt de Saccharomyces boulardii dans la tolerance digestive de la nutrition entérale à debit continu chez le brulé. [Use of Saccharomyces boulardii for the improvement of the tolerance of continuous enteral feeding in burn patients]Nutr Clin Metabol198713134 French
  • BleichnerGBlehautHMentecHMoyseDSaccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trialIntensive Care Med19972355175239201523
  • KelesidisTPothoulakisCEfficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disordersTher Adv Gastroenterol201252111125
  • Barreto-BergterEFigueiredoRTFungal glycans and the innate immune recognitionFront Cell Infect Microbiol2014414525353009
  • SamuelsenABSchrezenmeirJKnutsenSHEffects of orally administered yeast-derived β-glucans: a reviewMol Nutr Food Res201458118319324019098
  • VannucciLKrizanJSimaPImmunostimulatory properties and antitumor activities of glucans (Review)Int J Oncol201343235736423739801
  • GoodridgeHSReyesCNBeckerCAActivation of the innate immune receptor Dectin-1 upon formation of a ‘phagocytic synapse’Nature2011472734447147521525931
  • PothoulakisCReview article: anti-inflammatory mechanisms of action of Saccharomyces boulardiiAliment Pharmacol Ther200930882683319706150
  • MumyKLChenXKellyCPMcCormickBASaccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling eventsAm J Physiol Gastrointest Liver Physiol20082943G599G60918032477
  • Pontier-BresRMunroPBoyerLSaccharomyces boulardii modifies Salmonella typhimurium traffic and host immune responses along the intestinal tractPLoS One201498e10306925118595
  • RajputIRLiLYXinXEffect of Saccharomyces boulardii and Bacillus subtilis B10 on intestinal ultrastructure modulation and mucosal immunity development mechanism in broiler chickensPoult Sci201392495696523472019
  • MartinsFSVieiraATElianSDInhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Sac-charomyces boulardii against Salmonella infection in miceMicrobes Infect201315427027923376166
  • GirardPPansartYCoppeMCGillardinJMSaccharomyces boulardii inhibits water and electrolytes changes induced by castor oil in the rat colonDig Dis Sci200550112183219016240237
  • SchroederBWincklerCFailingKBrevesGStudies on the time course of the effects of the probiotic yeast Saccharomyces boulardii on electrolyte transport in pig jejunumDig Dis Sci2004497–81311131715387362
  • CzeruckaDRampalPEffect of Saccharomyces boulardii on cAMP-and Ca2+-dependent Cl-secretion in T84 cellsDig Dis Sci199944112359236810573387
  • BuccigrossiVLaudieroGRussoCChloride secretion induced by rotavirus is oxidative stress-dependent and inhibited by Saccharomyces boulardii in human enterocytesPLoS One201496e9983024918938
  • SchneiderSMGirard-PipauFFilippiJEffects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutritionWorld J Gastroenterol200511396165616916273644
  • BrevesGFaulKSchroderBHolstHCasparyWFSteinJApplication of the colon-simulation technique for studying the effects of Saccharomyces boulardii on basic parameters of porcine cecal microbial metabolism disturbed by clindamycinDigestion200061319320010773725
  • OeztuerkHSchroederBBeyerbachMBrevesGInfluence of living and autoclaved yeasts of Saccharomyces boulardii on in vitro ruminal microbial metabolismJ Dairy Sci20058872594260015956320
  • JahnHUUllrichRSchneiderTImmunological and trophical effects of Saccharomyces boulardii on the small intestine in healthy human volunteersDigestion1996572951048786007
  • ButsJPDe KeyserNDe RaedemaekerLSaccharomyces boulardii enhances rat intestinal enzyme expression by endoluminal release of polyaminesPediatr Res19943645225277816529
  • ButsJPDe KeyserNMarandiSSaccharomyces boulardii upgrades cellular adaptation after proximal enterectomy in ratsGut1999451899610369710
  • CastagliuoloILaMontJTNikulassonSTPothoulakisCSaccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileumInfect Immun19966412522552328945570
  • BrandaoRLCastroIMBambirraEAIntracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiaeAppl Environ Microbiol19986425645689464394
  • ButsJPDekeyserNStilmantCDelemESmetsFSokalESaccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylationPediatr Res2006601242916690953
  • TiagoFCMartinsFSSouzaELAdhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probioticsJ Med Microbiol201261Pt 91194120722580913
  • MartinsFSDalmassoGArantesRMInteraction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infectionPLoS One201051e892520111723
  • GedekBRAdherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardiiMycoses199942426126410424093
  • ZbindenRGöncziE-EAltweggMInhibition of Saccharomyces boulardii (nom. inval.) on cell invasion of Salmonella typhimurium and Yersinia enterocoliticaMicrob Ecol Health Dis2011113 ISSN 1651-2235
  • DucluzeauRBensaadaMComparative effect of a single or continuous administration of “Saccharomyces boulardii” on the establishment of various strains of “candida” in the digestive tract of gnotobiotic miceAnn Microbiol19821333491501 French
  • KamadaNChenGYInoharaNNunezGControl of pathogens and pathobionts by the gut microbiotaNat Immunol201314768569023778796
  • GeurtsLLazarevicVDerrienMAltered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissueFront Microbiol2011214921808634
  • EverardAMatamorosSGeurtsLDelzenneNMCaniPDSaccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db miceMBio201453e01011e0101424917595
  • AkilIYilmazOKurutepeSDegerliKKavukcuSInfluence of oral intake of Saccharomyces boulardii on Escherichia coli in enteric floraPediatr Nephrol200621680781016703374
  • De PreterVVanhoutteTHuysGSwingsJRutgeertsPVerbekeKEffect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjectsAliment Pharmacol Ther200623796397416573799
  • Girard-PipauFPompeiASchneiderSIntestinal microflora, short chain and cellular fatty acids, influence of a probiotic Saccharomyces boulardiiMicrob Ecolo Health Dis200214220227
  • VanhoutteTDe PreterVDe BrandtEVerbekeKSwingsJHuysGMolecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardiiAppl Environ Microbiol20067295990599716957220
  • KellyCAntibiotic-induced dysbiosis and corrective impact of S. boulardiiin healthy volunteers (Abstract-JFHOD conference)United Eur Gastroenterol J20142Suppl 1
  • OsowskaSSwidsinskiAKulikZLawinskiMPertkiewiczMImpact of saccharomyces boulardii on colonic microbiota and plasma lactate in short bowel syndrome patients on long term parenteral nutritionDig Dis Week20131445s895
  • SwidsinskiAAntibiotic-induced dysbiosis and corrective impact of S. boulardii – evaluation by structure functional FISH analysis in patients with a Gardnerella vaginalis infectionAbstract-JFHOD conference2014
  • SwidsinskiALoening-BauckeVSwidsinskiSSaccharomyces boulardii prevents the antibiotic induced changes in colonic microbiotaGastroenterology20131445 Suppl 1S-824
  • StaibLFuchsTMFrom food to cell: nutrient exploitation strategies of enteropathogensMicrobiology2014160Pt 61020103924705229
  • ChenSJLiuXWLiuJPYangXYLuFGUlcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrierWorld J Gastroenterol201420289468947525071341
  • WexlerHMBacteroides: the good, the bad, and the nitty-grittyClin Microbiol Rev200720459362117934076
  • ZitomerskyNLAtkinsonBJFranklinSWCharacterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel diseasePLoS One201386e6368623776434
  • ManzWAmannRLudwigWVancanneytMSchleiferKHApplication of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environmentMicrobiology1996142Pt 5109711068704951
  • YutinNGalperinMYA genomic update on clostridial phylogeny: Gram-negative spore formers and other misplaced clostridiaEnviron Microbiol201315102631264123834245
  • VitalMHoweACTiedjeJMRevealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic dataMBio201452e0088924757212
  • NCBI Taxomomy BrowserTaxomomy Browser Available from: http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgiAccessed July 2, 2015
  • KabeerdossJSankaranVPugazhendhiSRamakrishnaBSClostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inflammatory bowel disease: a case-control study in IndiaBMC Gastroenterol2013132023351032
  • SokolHPigneurBWatterlotLFaecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut micro-biota analysis of Crohn disease patientsProc Natl Acad Sci U S A200810543167311673618936492
  • QiuXZhangMYangXHongNYuCFaecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitisJ Crohns Colitis2013711e558e56823643066
  • KumariACatanzaroRMarottaFClinical importance of lactic acid bacteria: a short reviewActa Biomed201182317718022783712
  • TurpinWHumblotCThomasMGuyotJPLactobacilli as multifaceted probiotics with poorly disclosed molecular mechanismsInt J Food Microbiol201014338710220801536
  • IqbalMZQadirMIHussainTJanbazKHKhanYHAhmadBReview: probiotics and their beneficial effects against various diseasesPak J Pharm Sci201427240541524577933
  • LayCRigottier-GoisLHolmstromKColonic microbiota signatures across five northern European countriesAppl Environ Microbiol20057174153415516000838
  • ThiennimitrPWinterSEWinterMGIntestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiotaProc Natl Acad Sci U S A201110842174801748521969563
  • Philippe-TaineGCorolerLLevyRGillardinJDose-dependent preventive effect of Saccharomyces boulardii on clindamycin-induced alterations in intestinal aerobic flora of the hamsterMicrobial Ecol Health Dis200315126130
  • CollignonASandreCBarcMCSaccharomyces boulardii module les propriétés des cellules dendritiques et le déséquilibre du microbiote intestinal après un traitement antibiotique [Saccharomyces boulardii modulates dendritic cell properties and intestinal microbiota disruption after antibiotic treatment]Gastroenterol Clin Biol201034Suppl 1S71S78 French20889009
  • DubourgGLagierJCArmougomFHigh-level colonisation of the human gut by Verrucomicrobia following broad-spectrum antibiotic treatmentInt J Antimicrob Agents201341214915523294932
  • BradlowHLObesity and the gut microbiome: pathophysiological aspectsHormone Mol Biol Clin Invest20141715361
  • ScanlanPDShanahanFMarchesiJRHuman methanogen diversity and incidence in healthy and diseased colonic groups using mcrA gene analysisBMC Microbiol200887918492229
  • LoyAMaixnerFWagnerMHornMprobeBase – an online resource for rRNA-targeted oligonucleotide probes: new features 2007Nucleic Acids Res200735Database issueD800D80417099228
  • TurnbaughPJLeyREMahowaldMAMagriniVMardisERGordonJIAn obesity-associated gut microbiome with increased capacity for energy harvestNature200644471221027103117183312
  • SghirAGrametGSuauARochetVPochartPDoreJQuantification of bacterial groups within human fecal flora by oligonucleotide probe hybridizationAppl Environ Microbiol20006652263226610788414
  • MatsukiTWatanabeKFujimotoJTakadaTTanakaRUse of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human fecesAppl Environ Microbiol200470127220722815574920
  • FranksAHHarmsenHJRaangsGCJansenGJSchutFWellingGWVariations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probesAppl Environ Microbiol1998649333633459726880
  • HarmsenHJWildeboer-VelooACGrijpstraJKnolJDegenerJEWellingGWDevelopment of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groupsAppl Environ Microbiol200066104523452711010909